FDA is issuing a final rule to require
certain infectious disease testing, donor screening, and
recordkeeping to help prevent the transmission of the human
immunodeficiency virus (HIV) and hepatitis viruses through human
tissue used in transplantation. The final rule requires facilities
engaged in the recovery, screening, testing, processing, storing,
or distributing of human tissues to ensure that specified minimum
required medical screening and infectious disease testing has been
performed and that records documenting such screening and testing
for each human tissue are available for inspection by FDA.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.